Shantsila A, Lip GYH. Malignant Hypertension Revisited-Does This Still Exist? Am J Hypertens. 2017;30:543–9.

Article  PubMed  Google Scholar 

Cremer A, Amraoui F, Lip GYH, Morales E, Rubin S, Segura J, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Human Hypertens. 2016;30:463–6.

Article  CAS  Google Scholar 

van den Born BJH, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens. 2007;20:900–6.

Article  PubMed  Google Scholar 

Shantsila A, Shantsila E, Beevers DG, Lip GYH. Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. J Hypertens. 2017;35:2310–4.

Article  CAS  PubMed  Google Scholar 

Keith NM, Wagener HP. Kernohan JW. The syndrome of malignant hypertension. Arch Internal Med. 1928;41:141–88.

Article  Google Scholar 

Lip GY, Beevers M, Beevers G. The failure of malignant hypertension to decline: a survey of 24 years’ experience in a multiracial population in England. J Hypertens. 1994;12:1297–305.

Article  CAS  PubMed  Google Scholar 

van den Born BJH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5:37–46.

Article  PubMed  Google Scholar 

Rubin S, Cremer A, Boulestreau R, Rigothier C, Kuntz S, Gosse P. Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort. J Hypertens. 2018;36:1–9.

Google Scholar 

Boulestreau R, Lucas L, Cremer A, Debeugny S, Rubin S, Gaudissard J, et al. Neurologically asymptomatic patients frequently present cerebral injuries during malignant hypertension: a MRI study. J Hypertens. 2021;39:2463–9.

Article  CAS  PubMed  Google Scholar 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.

Article  CAS  PubMed  Google Scholar 

Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411–7.

Article  CAS  PubMed  Google Scholar 

Fazekas F, Chawluk JBAA. MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging. AJR. Am J Roentgenol. 1987;149:351–6.

Article  CAS  Google Scholar 

Zhu YC, Dufouil C, Mazoyer B, Soumaré A, Ricolfi F, Tzourio C, et al. Frequency and location of dilated Virchow-Robin spaces in elderly people: A population-based 3D MR imaging study. Am J Neuroradiol. 2011;32:709–13.

Article  PubMed  PubMed Central  Google Scholar 

Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–38.

Article  PubMed  PubMed Central  Google Scholar 

Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228–34.

Article  PubMed  PubMed Central  Google Scholar 

Denolle T, Asmar R, Boivin JM, Girerd X, Le Jeune S, Vaisse B, et al. Recommandations sur la mesure de la pression artérielle. Consensus d’experts de la Société française d’hypertension artérielle, filiale de la Société française de cardiologie. La Presse Médicale. 2019;48:1319–28.

Article  PubMed  Google Scholar 

Jochems ACC, Arteaga C, Chappell F, Ritakari T, Hooley M, Doubal F, et al. Longitudinal Changes of White Matter Hyperintensities in Sporadic Small Vessel Disease: A Systematic Review and Meta-analysis. Neurology. 2022;99:e2454–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.

Article  PubMed  PubMed Central  Google Scholar 

Amraoui F, Bos S, Vogt L, van den Born BJ. Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study. BMC Nephrol. 2012;13:71.

Article  PubMed  PubMed Central  Google Scholar 

Bretzner M, Bonkhoff AK, Schirmer MD, Hong S, Dalca AV, Donahue KL, et al. MRI Radiomic Signature of White Matter Hyperintensities Is Associated With Clinical Phenotypes. Front Neurosci. 2021;15:691244.

Article  PubMed  PubMed Central  Google Scholar 

Min ZG, Shan HR, Xu L, Yuan DH, Sheng XX, Xie WC, et al. Diffusion tensor imaging revealed different pathological processes of white matter hyperintensities. BMC Neurol. 2021;21:128.

Article  PubMed  PubMed Central  Google Scholar 

Armstrong NJ, Mather KA, Sargurupremraj M, Knol MJ, Malik R, Satizabal CL, et al. Common Genetic Variation Indicates Separate Causes for Periventricular and Deep White Matter Hyperintensities. Stroke. 2020;51:2111–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iadecola C, Yaffe K, Biller J, Bratzke LC, Faraci FM, Gorelick PB, et al. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension. 2016;68:e67–94.

Article  CAS  PubMed  Google Scholar